Nvidia's $20B Groq Deal: Strategy, LPU Tech & Antitrust
Learn why Nvidia acquired Groq's assets for $20B. We analyze the deal's structure, Groq's low-latency LPU technology, and the strategy to avoid antitrust review
Back to Articles
Articles tagged with “nvidia”
NVIDIA AI GPU Pricing: A Guide to H100 & H200 Costs
An educational guide to NVIDIA AI GPU pricing. We analyze the cost of H100 & H200 GPUs, market factors, HBM memory costs, and compare purchase vs. cloud rental.
Oracle & OpenAI's $300B Deal: AI Infrastructure Analysis
An in-depth analysis of the $300B Oracle-OpenAI cloud computing deal. Learn about the financial risks, AI infrastructure build-out, and Stargate project goals.
Blackwell vs Hopper: A Deep Dive GPU Architecture Comparison
Explore the Nvidia Blackwell vs Hopper GPU architectures. Learn the key technical differences in tensor cores (FP4/FP6), memory, and performance for AI vs HPC.
AI Bubble vs. Dot-com Bubble: A Data-Driven Comparison
Explore a data-driven comparison of the AI boom and the dot-com bubble. We analyze key metrics like valuations, profitability, and VC funding to see if this is
OpenAI-AMD AI Hardware Partnership: A Strategic Analysis
This article examines the OpenAI-AMD strategic partnership, detailing the GPU supply terms, stock warrants, and the advantages and risks for AI hardware strateg
Dario Amodei, Demis Hassabis & Jensen Huang: Compressing a Century of Biology into a Decade
How AI leaders like Amodei, Hassabis, and Huang are accelerating drug discovery, genomics, and life science breakthroughs—compressing decades into years. Updated January 2026 with AlphaFold 3, Claude for Life Sciences, NVIDIA Evo 2, and $3B+ pharma partnerships.
Powering Pharma AI with NVIDIA H100 and Blackwell GPUs
A comprehensive analysis of how pharmaceutical and biotech companies are leveraging NVIDIA's latest H100 and Blackwell GPUs to accelerate drug discovery, protein structure prediction, and AI-driven research, with detailed case studies from leading companies.